Advanced Medicine

Collaboration and thoughtful automation at scale will be critical for unlocking cell and gene therapies for patients

An interview on the development of Amtagvi – the world’s first approved T-cell therapy for a solid tumor.

Sitting Down With… Claudia Zylberberg, Akron Bio Founder and ICST Presidential Nominee

Large study shows secondary tumors after CAR-T cancer therapies are rare

How metabolic conditioning could improve cell therapy potency and persistence.

We dive into the archive of 2019 for insight and inspiration – this time with Bruce Levine.

Sitting Down With… Stella Vnook, CEO, Likarda

Why companies must tighten their supply chains in light of Chinese anti-espionage laws and other regulatory clampdowns.

The past, present, and future of gene editing.

Cancer vaccines are compelling but there are challenges that must be faced. Experts give their view.